Quantum BioPharma Ltd. (QNTM)
Develops drug candidates for multiple sclerosis, depression, and inflammatory diseases.
$3.00+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-87.3%
The outlook
QNTM trades at $3, sitting well below both its 50- and 200-day moving averages and near the bottom of its 52-week range. Analyst coverage shows an average price target around $12.36, roughly 312% above current levels, though the overall sentiment leans bearish. The stock's positioning suggests it's deeply depressed relative to recent history and analyst expectations.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +312% vs current price
Market cap
$19.2M
52-wk high
$31.91
52-wk low
$2.07
50-day avg
$4.48
200-day avg
$6.18
Trailing P/E
—